{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:17:46Z","timestamp":1787872666636,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejso.2026.111978","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:38:17Z","timestamp":1782455897000},"page":"111978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systematic total parietal peritonectomy for peritoneal mesothelioma-perioperative and oncological outcomes in an Indian cohort of 100 patients"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3295-0006","authenticated-orcid":false,"given":"Mufaddal","family":"Kazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4498-7612","authenticated-orcid":false,"given":"Avanish","family":"Saklani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Kammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Desouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Sukumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viraj","family":"Lavingia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanket","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9808-6898","authenticated-orcid":false,"given":"Aditi","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejso.2026.111978_bib1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11864-002-0003-6","article-title":"Peritoneal mesothelioma","volume":"3","author":"Mohamed","year":"2002","journal-title":"Curr Treat Options Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111978_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5588\/pha.25.0006","article-title":"The rationale for cancer to be made a notifiable disease in India","volume":"15","author":"Singh","year":"2025","journal-title":"Public Health Action"},{"key":"10.1016\/j.ejso.2026.111978_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5588\/pha.24.0003","article-title":"Analysis of mesothelioma cases and National Cancer Registry data to assess asbestos exposure in India","volume":"14","author":"Singh","year":"2024","journal-title":"Public Health Action"},{"key":"10.1016\/j.ejso.2026.111978_bib4","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","article-title":"Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"49","author":"Baratti","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2026.111978_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.6363","article-title":"The role of hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei after cytoreductive surgery","volume":"156","author":"Kusamura","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2026.111978_bib6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ejso.2022.10.022","article-title":"What are the preoperative predictors of a futile pelvic exenteration in rectal cancers?","volume":"49","author":"Kazi","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111978_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1245\/s10434-008-0219-1","article-title":"Diffuse malignant peritoneal mesothelioma: failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"16","author":"Baratti","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111978_bib8","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1245\/s10434-012-2237-2","article-title":"Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study","volume":"19","author":"Baratti","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111978_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/02656736.2018.1503345","article-title":"Treading the beaten path with old and new obstacles: a report from the Indian HIPEC registry","volume":"35","author":"Bhatt","year":"2018","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.ejso.2026.111978_bib10","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/cncr.25640","article-title":"A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database","volume":"117","author":"Yan","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2026.111978_bib11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1245\/s10434-023-13640-y","article-title":"Impact of perioperative systemic chemotherapy on survival for patients who have diffuse malignant peritoneal mesothelioma treated with CRS-HIPEC","volume":"31","author":"Chatterjee","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111978_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"1","key":"10.1016\/j.ejso.2026.111978_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111978_bib14","doi-asserted-by":"crossref","first-page":"7803","DOI":"10.1245\/s10434-023-13973-8","article-title":"PSOGI consensus on HIPEC regimens for peritoneal malignancies: diffuse malignant peritoneal mesothelioma","volume":"30","author":"Kepenekian","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111978_bib15","unstructured":"Common Terminology Criteria for adverse events (CTCAE) ."},{"issue":"10","key":"10.1016\/j.ejso.2026.111978_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.110306","article-title":"Impact of diaphragmatic intervention in cytoreductive surgery with heated intraperitoneal chemotherapy for colorectal carcinoma","volume":"51","author":"Williams","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111978_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/bjs5.50256","article-title":"Clinical and surgical outcomes of patients with peritoneal mesothelioma discussed at a monthly national multidisciplinary team video-conference meeting","volume":"4","author":"Brandl","year":"2020","journal-title":"BJS Open"},{"key":"10.1016\/j.ejso.2026.111978_bib18","article-title":"Consensus guideline for the management of peritoneal mesothelioma","author":"Brown","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111978_bib19","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/cancers15030662","article-title":"Diagnostic and therapeutic pathway in diffuse malignant peritoneal mesothelioma","volume":"15","author":"Kusamura","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejso.2026.111978_bib20","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41379-020-00688-4","article-title":"Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases","volume":"34","author":"Chapel","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejso.2026.111978_bib21","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/02656736.2021.1903585","article-title":"Multicystic peritoneal mesothelioma treated with cytoreductive surgery followed or not by hyperthermic intraperitoneal chemotherapy: results from a large multicentric cohort","volume":"38","author":"Kepenekian","year":"2021","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.ejso.2026.111978_bib22","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2019-0024","article-title":"Multicystic peritoneal mesothelioma: a systematic review of the literature","volume":"4","author":"Noiret","year":"2019","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.ejso.2026.111978_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s13193-017-0693-7","article-title":"Setting up of the Indian HIPEC registry: a registry for Indian patients with peritoneal surface malignancies","volume":"8","author":"Bhatt","year":"2017","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111978_bib24","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s13193-025-02272-1","article-title":"The INDEPSO-ISPSM consensus on peritoneal malignancies-diagnosis and management of peritoneal mesothelioma","volume":"16","author":"Chatterjee","year":"2025","journal-title":"Indian J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111978_bib25","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1245\/s10434-020-08918-4","article-title":"Total parietal peritonectomy can be performed with acceptable morbidity for patients with advanced ovarian cancer after neoadjuvant chemotherapy: results from a prospective multi-centric study","volume":"28","author":"Bhatt","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111978_bib26","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111978_bib27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00428-021-03144-z","article-title":"Combined grade and nuclear grade are prognosis predictors of epithelioid malignant peritoneal mesothelioma: a multi-institutional retrospective study","volume":"479","author":"Benzerdjeb","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ejso.2026.111978_bib28","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1245\/s10434-015-4962-9","article-title":"The role of Ki-67 and pre-cytoreduction parameters in selecting diffuse malignant peritoneal mesothelioma (DMPM) patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"23","author":"Kusamura","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111978_bib29","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/jso.27947","article-title":"Multisocietal consensus on the use of cytoreductive surgery and HIPEC for the treatment of diffuse malignant peritoneal mesothelioma: a GRADE approach for evidence evaluation and recommendation","volume":"131","author":"Kusamura","year":"2025","journal-title":"J Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326005974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326005974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:33:31Z","timestamp":1787870011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326005974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0748798326005974"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111978","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic total parietal peritonectomy for peritoneal mesothelioma-perioperative and oncological outcomes in an Indian cohort of 100 patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111978","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111978"}}